Review

The potential role of transforming growth factor beta family ligand interactions in prostate cancer

  • Received: 19 October 2016 Accepted: 25 January 2017 Published: 13 February 2017
  • The transforming growth factor beta (TGF-β) family plays an important role in embryonic development and control of the cell cycle. Members of the TGF-β family have pleiotropic functions and are involved in both the inhibition and progression of various cancers. In particular, deregulation of the TGF-β family has been associated with prostate cancer, as both a mechanism of disease progression and a possible therapeutic target. This review concentrates on the TGF-βs, activins and inhibins, bone morphogenetic proteins and NODAL and their connection to prostate cancer. Whilst most studies examine the family members in isolation, there are multiple interactions that may occur between members which can alter their function. Such interactions include ligand competition for receptor binding and shared intracellular pathways such as the Mothers against decapentaplegic (SMAD) proteins. Another mechanism for interaction within the TGF-β family is facilitated by their dimeric structure; heterodimers can form which exhibit different functional capabilities to their homodimeric counterparts. The potential formation of TGF-β family heterodimers has not been well examined in prostate cancer. The multiple methods of interrelations between members highlights the need for gross analysis of the TGF-β family and related factors in association with prostate cancer, in order to discover possible future avenues for TGF-β based diagnosis and treatments of the disease. This review describes the role of the TGF-β family of proteins in cancer and, in particular, prostate cancer. After a brief overview, the role of individual members of the family is considered and how these members may be involved in prostate cancer growth is discussed. The review highlights the complex interactions that occur between family members and that may contribute to the progression of prostate cancer.

    Citation: Kit P. Croxford, Karen L. Reader, Helen D. Nicholson. The potential role of transforming growth factor beta family ligand interactions in prostate cancer[J]. AIMS Molecular Science, 2017, 4(1): 41-61. doi: 10.3934/molsci.2017.1.41

    Related Papers:

    [1] Usman Saeed . Wood cellulose fibers reinforced polylactic acid composite: mechanical, thermomechanical characteristics and orientation of fiber. AIMS Materials Science, 2020, 7(1): 9-23. doi: 10.3934/matersci.2020.1.9
    [2] Lubna Layth Dawood, Ehsan Sabah AlAmeen . Influence of infill patterns and densities on the fatigue performance and fracture behavior of 3D-printed carbon fiber-reinforced PLA composites. AIMS Materials Science, 2024, 11(5): 833-857. doi: 10.3934/matersci.2024041
    [3] Timothy K. Mulenga, Albert U. Ude, Chinnasamy Vivekanandhan . Concise review on the mechanical characteristics of hybrid natural fibres with filler content. AIMS Materials Science, 2020, 7(5): 650-664. doi: 10.3934/matersci.2020.5.650
    [4] João Otávio Donizette Malafatti, Thamara Machado de Oliveira Ruellas, Camila Rodrigues Sciena, Elaine Cristina Paris . PLA/starch biodegradable fibers obtained by the electrospinning method for micronutrient mineral release. AIMS Materials Science, 2023, 10(2): 200-212. doi: 10.3934/matersci.2023011
    [5] Bandar Abdullah Aloyaydi, Subbarayan Sivasankaran, Hany Rizk Ammar . Influence of infill density on microstructure and flexural behavior of 3D printed PLA thermoplastic parts processed by fusion deposition modeling. AIMS Materials Science, 2019, 6(6): 1033-1048. doi: 10.3934/matersci.2019.6.1033
    [6] Mohamed Samy El-Feky, Passant Youssef, Ahmed Maher El-Tair, Sara Ibrahim, Mohamed Serag . Effect of nano silica addition on enhancing the performance of cement composites reinforced with nano cellulose fibers. AIMS Materials Science, 2019, 6(6): 864-883. doi: 10.3934/matersci.2019.6.864
    [7] Leticia Martinez, Den Palessonga, Philippe Roquefort, Alexis Chevalier, Azar Maalouf, Julien Ville, Vincent Laur . Development of a high temperature printable composite for microwave absorption applications. AIMS Materials Science, 2021, 8(5): 739-747. doi: 10.3934/matersci.2021044
    [8] Md Shamsuddoha, Md Mainul Islam, Thiru Aravinthan, Allan Manalo, Luke P. Djukic . Effect of hygrothermal conditioning on the mechanical and thermal properties of epoxy grouts for offshore pipeline rehabilitation. AIMS Materials Science, 2016, 3(3): 832-850. doi: 10.3934/matersci.2016.3.832
    [9] Zulzamri Salleh, Md Mainul Islam, Jayantha Ananda Epaarachchi, Haibin Su . Mechanical properties of sandwich composite made of syntactic foam core and GFRP skins. AIMS Materials Science, 2016, 3(4): 1704-1727. doi: 10.3934/matersci.2016.4.1704
    [10] Harikrishnan Pulikkalparambil, Jyotishkumar Parameswaranpillai, Jinu Jacob George, Krittirash Yorseng, Suchart Siengchin . Physical and thermo-mechanical properties of bionano reinforced poly(butylene adipate-co-terephthalate), hemp/CNF/Ag-NPs composites. AIMS Materials Science, 2017, 4(3): 814-831. doi: 10.3934/matersci.2017.3.814
  • The transforming growth factor beta (TGF-β) family plays an important role in embryonic development and control of the cell cycle. Members of the TGF-β family have pleiotropic functions and are involved in both the inhibition and progression of various cancers. In particular, deregulation of the TGF-β family has been associated with prostate cancer, as both a mechanism of disease progression and a possible therapeutic target. This review concentrates on the TGF-βs, activins and inhibins, bone morphogenetic proteins and NODAL and their connection to prostate cancer. Whilst most studies examine the family members in isolation, there are multiple interactions that may occur between members which can alter their function. Such interactions include ligand competition for receptor binding and shared intracellular pathways such as the Mothers against decapentaplegic (SMAD) proteins. Another mechanism for interaction within the TGF-β family is facilitated by their dimeric structure; heterodimers can form which exhibit different functional capabilities to their homodimeric counterparts. The potential formation of TGF-β family heterodimers has not been well examined in prostate cancer. The multiple methods of interrelations between members highlights the need for gross analysis of the TGF-β family and related factors in association with prostate cancer, in order to discover possible future avenues for TGF-β based diagnosis and treatments of the disease. This review describes the role of the TGF-β family of proteins in cancer and, in particular, prostate cancer. After a brief overview, the role of individual members of the family is considered and how these members may be involved in prostate cancer growth is discussed. The review highlights the complex interactions that occur between family members and that may contribute to the progression of prostate cancer.


    Abbreviations

    Fibre Reinforced PolymerFRP
    Poly(lactic acid)PLA
    Glycerol triacetateGTA
    Bleached softwood kraft pulpBSKP
    Size exclusion chromatographySEC
    Number average molecular weightMn
    Weight average molecular weightMw
    Polydispersity indexPD

    1. Introduction

    Currently, the majority of the commercial available Fibre Reinforced Polymer (FRP) composites in e.g. automotive industry are based on petroleum-based polymers (either thermoset or thermoplastic) reinforced with synthetic fibres such as carbon fibre, aramid fibre and glass fibre [1]. However, environmental concerns are pushing industries for the use of renewable and bio-based materials. The focus of environmentally friendly composites has led to investigations of alternative constituents for composites. For example, poly(lactic acid) (PLA), a thermoplastic biopolymer, has been considered as one of the most promising material to replace petroleum-based plastics in a wide range of applications. PLA offers a competitive and CO2 neutral basis to polyolefin and bulk polymer based composites. Moreover, use of PLA reduces dependency on oil for the production of composite materials. However, the major concerns of PLA biopolymers are their low impact strength, narrow processing window, poor fibre-matrix compatibility and moisture absorption [2,3]. Another drawback related to PLA is its tendency to hydrolytic degradation under melt processing conditions in the presence of moisture [4], which remains a challenge when processing PLA reinforced natural fibre composites.

    Natural fibres are hygroscopic by nature with 6-10 wt% moisture content at 50-70% relative humidity conditions [5]. Moisture absorption of natural fibres often leads to swelling and presence of voids at the interface. In general, to avoid drawbacks related to moisture, PLA and natural fibres have been dried prior to processing biocomposites to remove most of water [2,6,7,8,9,10]. Some studies do not mention drying PLA and natural fibres prior to processing [11,12]. Besides fibre drying, cellulose fibre modification is another way to decrease moisture absorption of the produced PLA/cellulose composites [13].

    Studies on the influence of moisture in natural fibres on the properties of PLA composites have been published. Fujiura et al. [14] demonstrated the decrease of the average molecular weight of PLA as the moisture content of the jute fibre increased in the composite. The mechanical properties of the composites were also decreased due to the hydrolysis. Eliminating moisture from the long jute fibres (LJF) in the preparation process of the LJF/PLA pellets was found to be important for preventing the deterioration in the molecular weight of PLA and the mechanical performance of the composites. Another study concluded that 6-9 wt% moisture present in the natural fibres did not cause fatal PLA degradation during compounding time of 13 min [5]. A low moisture content of 0.2-0.4 wt% in the fibres did not have large impact on the morphological and mechanical properties of the PLA/natural fibre composites. Molar mass analysis revealed that not all water molecules available in the fibres caused PLA cleavage in the melt compounded PLA/natural fibre samples. This was explained by the variable fibre-PLA contact surface area, which is related to the fibre or the fibre bundle diameter.

    Cellulose fibres are sensitive to melt processing conditions and suffer morphological changes caused by the high processing temperatures and high shear forces of the extruders and injection moulding machines [15]. The fibre breakage during the composite manufacturing process causes of the reduction of the composites’ mechanical properties. Therefore, several papers have investigated natural fibre damage (cutting) during the melt processing of thermoplastic composites. Longer cellulose fibres have exhibited higher length reduction during the compounding than shorter fibres [16,17,18]. In most cases shorter cellulose fibres showed better fibre dispersion in the thermoplastic matrix than longer fibres [16,19]. The improved performance of the composite has been explained by the even dispersion of natural fibres in polymer matrix, good fibre-matrix adhesion and higher stiffness of the fibres. The viscosity of the melt, which determines shear forces, can be influenced by the polymer [20], the fibre and plasticizer content [21], and the compounding system [22]. Peltola et al. [18] succeeded to reduce the wood fibre degradation in the polypropylene composites by using lower shear forces during the melt processing. However, low screw rotation speed during compounding hindered the formation of good dispersion of wood fibres in the polymer matrix. Generally, use of tougher compounding conditions, better fibre dispersion and interfacial adhesion between fibres and polymer matrix can be achieved at the cost of greater degradation of cellulose fibres [23,24,25,26].

    Mechanical properties of wood pulp fibres depend on their moisture content. Considerable stiffening of fibres takes place with decreasing moisture content, which is often called hornification. Hornification can be reversible or irreversible. Hornification phenomenon is associated with the formation of irreversible or partially irreversible hydrogen bonds in cellulose upon drying or water removal [27,28]. Drying of wood pulp fibres is accompanied by shrinkage of the internal fibre volume due to structural changes in wood pulp fibres caused by the removal of water molecules [27]. In the case of irreversible hornification the original water-swollen state is not regained after resuspension of fibres in water [29]. Hornification is especially well-known in papermaking processes. The use of stiff, hornified and once-dried fibres results in reduced strength properties of paper to be made of them [27]. On the other hand, when the shrinkage is prevented during drying of paper, the water removal results in increased shrinkage stresses, higher elastic modulus and strength of fibres and paper [30]. This takes place regardless of possible irreversible hornification.

    When studying the hornification phenomenon of the never-dried kraft pulp fibres during water removal, Weise et al. [31] showed that the fibre shrinkage occurs in two different phases. Even the removal of “free” water in the initial phase of drying results in some hornification and leads to shrinkage of fibre wall thickness, when the gaps between the lamellae of the fibre cell wall become dewatered. In the second phase, removal of bound water causes a rapid and isotropic shrinkage of the fibre cross-section. Hornification was also detected when removing the last few percent of water from the air-dried fibres, which restricted the fibre re-swellability regarding the fibre width. The hornification was especially high with the never-dried bleached kraft pulp fibres [31].

    Using moist fibres of kraft pulp in the melt processing of PLA could be the ideal, simple and cost-effective route to fabricate composites. However, there is lack of research dealing with this topic and detailed analysis is needed to gain a deeper understanding on how those compounds behave during the melt processing and how the optimal performance of the composites could be reached. Herrera et al. [32] succeeded to reinforce PLA using aqueous dispersion with 9.5 wt% of the nanofibres for the liquid feeding in the extrusion. Glycerol triacetate (GTA) was used as a processing aid to facilitate the nanofiber dispersion and as a liquid medium for their feeding. Recently, a simple and efficient method for the manufacturing of the thermoplastic composite using wet natural fibres was invented by Nikkilä and Ture [33]. In this method a wet mixture of natural fibres was compounded with a thermoplastic polymer and a compatibility improving agent in an extruder followed by mechanical pressing. By using high pressures and temperatures, water can be efficiently removed from the inner structure of the fibre and fibre may be worked into a more advantageous form in the melt mixing.

    In this study, never-dried bleached softwood kraft pulp (BSKP) was used for feeding in the compounding with PLA without any processing additives. Moisture content of the BSKP was adjusted to 1, 3, 16 and 25% in a conditioning chamber and/or flow dryer before the compounding stage. Subsequently, the PLA/BSKP specimens were prepared by the injection moulding. The properties of the composites were investigated from a viewpoint of clarifying the effect of the moist kraft pulp fibres on the average molecular weight of PLA after processing and the mechanical performance of the composite. The study also evaluates the advantage of using the moist BSKP to prevent damage to the BSKP fibres during the melt processing. The fibre dispersion in the PLA matrix was also examined.


    2. Materials and Methods


    2.1. Materials

    Poly(lactic acid) (PLA) (Natureworks®, 3052D grade) was used a matrix polymer for the preparation of the PLA/bleached softwood kraft pulp (BSKP) composites. Never-dried bleached softwood kraft pulp made from spruce was delivered by Stora Enso. The PLA samples containing 30 wt% of BSKP with 1, 3, 16 and 25% moisture contents were prepared and denoted as PLA/BSKP1, PLA/BSKP3, PLA/BSKP16 and PLA/BSKP25, respectively.


    2.2. Processing

    PLA composites with bleached softwood kraft pulp content of 30 wt% were prepared using a co-rotating twin-screw extruder (Berstorff GmbH ZE 25x33 D). Diameters and lengths of the screws of the twin-screw extruder were 25 mm and 870 mm respectively. The extruder zone temperatures ranged from 60 to 195 °C.

    The moisture content of the bleached softwood kraft pulp was adjusted prior to compounding:

    - BSKP1 sample was dried in the flow dryer at 50 °C for 30 minutes. Drying of BSKP1 was continued in an oven at 50 °C for 4 hours and in a vacuum-oven at 50 °C for 2 hours.

    - BSKP3 sample was dried in the flow dryer at 50 °C for 30 minutes.

    - BSKP16 sample was kept in a conditioning chamber (WTB Binder KBF-115) at 30 °C and 75% RH for 24 hours. Drying of BSKP16 was continued at 25 °C and 50% RH overnight. Finally, BSKP16 sample was dried in the flow dryer at 30 °C for 15 minutes.

    - BSKP25 sample was kept in a conditioning chamber (WTB Binder KBF-115) at 30 °C and 75% RH for 24 hours. Finally, BSKP25 sample was dried in the flow dryer at 30 °C for 15 minutes.

    Vacuum was used during the compounding to remove excess water. Samples were compounded under nitrogen and a vacuum of 500 mbar was applied. The compositions of the prepared composites and the initial moisture contents of bleached softwood krat pulp before compounding are presented in Table 1. The moisture contents of BSKP were determined with a moisture analyser Precisa XM 50.

    Table 1.Compositions of the produced composites and moisture contents of the bleached softwood kraft pulp (BSKP) before compounding
    Sample code Bleached softwood kraft pulp (wt%) PLA (wt%) Moisture content of bleached softwood kraft pulp before compounding (%)
    PLA - 100 -
    PLA/BSKP1 30 70 1
    PLA/BSKP3 30 70 3
    PLA/BSKP16 30 70 16
    PLA/BSKP25 30 70 25
     | Show Table
    DownLoad: CSV

    After compounding, the PLA/BSKP samples were injection moulded with an injection-moulding machine (Engel ES 200/50 HL) to dumbbell shape specimens according to ISO 3167. At least 25 injection moulded specimens for each sample material were prepared. Neat PLA specimen was prepared following the same processing parameters and used as reference. Figure 1 illustrates the injection moulded PLA and PLA/BSKP samples.

    Figure 1. Injection moulded tensile test specimens of PLA composites containing 30 wt% of BSKP with four different moisture contents: (a) neat PLA, (b) PLA/BSKP1, (c) PLA/BSKP3, (d) PLA/BSKP16 and (e) PLA/BSKP25

    2.3. Fibre Length Analysis

    For determination the BSKP fibre lengths, the fibre fraction of injection moulded PLA samples was Soxhlet-extracted. A small amount of composite sample was placed into the Soxhlet thimble and continuously fluxed with a hot solution of chloroform for 48 h. The remaining kraft pulp fibre fraction was collected and the fibre lengths were determined using a Kajaani Fiberlab analyser. Some 0.23-0.30 g of each sample was soaked in 500 ml deionized water and they were dispersed using a high shear laboratory blender (IKA Ultra-Turrax T18) for five minutes. After dispersing the samples were left in deionized water overnight. Next day the samples were further mixed in five litres of water with an impeller for 10 minutes. Some 50 ml of dispersed sample was pipetted into the analyser and fibre analysis was performed with two repeat measurements. Fibre length results were reported according to TAPPI standard method T271.


    2.4. Size Exclusion Chromatography (SEC)

    The average molar masses and polydispersity index of the samples before and after the melt processing steps were determined using size exclusion chromatography (SEC) coupled with a refractive index detector (Waters 2412).

    The PLA/BSKP samples were prepared for SEC analysis by dissolving in chloroform overnight at room temperature. Each solution concentration was 1 mg/ml. Before injection, the samples were filtered through a 0.45 µm GHP filter. Styragel HR 4 and 3 columns with a pre-column were used in the SEC measurements. Separations were performed at 30 °C using chloroform as eluent at a flow rate of 0.6 mL min−1. Three parallel samples were analysed for each composite. The data obtained with Waters 2412 detector were analysed with Waters Empower 3 software. The molar mass distributions (MMD) were calculated against 8 x polystyrene (PS) (1260-1030000 g mol−1) standards, using Waters Empower 3 software. The average molar masses and polydispersity of the samples were calculated using the following equations:

    The number average molecular weight, Mn

    Mn=ΣNiMiΣNi

    where Mi is the molecular weight of a chain and Ni is the number of chains of that molecular weight.

    Weight average molecular weight, Mw

    Mw=ΣNiMi2ΣNiMi

    Polydispersity index, PD

    PD=MwMn

    2.5. Mechanical Testing

    Tensile tests were performed using an Instron 4505 Universal Tensile Tester (Instron Corp., Canton, MA, USA) and an Instron 2665 Series High Resolution Digital Automatic Extensometer (Instron Corp., Canton, MA, USA) with a 10 kN load cell and a 5 mm/min cross-head speed. The ISO-527 and ISO-179 standards were used in the mechanical testing of the specimens. Five specimens were tested for each sample material to obtain the average values of the tensile properties. Impact strengths were determined by using a Charpy Ceast Resil 5.5 Impact Strength Machine (CEAST S.p.a., Torino, Italy). Charpy impact strength tests in edgewise orientation was applied to the unnotched specimens. Impact testing was conducted in sets of ten replicates to obtain an average value and variance. The test specimens were kept in standard conditions (23 °C, 50% relative humidity) for at least five days before testing.


    3. Results and Discussion


    3.1. Fibre Length

    Damage of the natural fibre during the composite melt processing steps is one of the main reasons of the reduction of the composites’ mechanical properties such as strength and stiffness. For this reason, retaining fibre length is desirable for the improved strength and stiffness of the composite. In the present work by using moist BSKP less hornification and kraft pulp fibre cutting is expected. The BSKP fibre lengths were determined from the compounded and injection moulded PLA samples (Table 2).

    Table 2.Fibre lengths of the bleached softwood kraft pulp (BSKP) before and after processing
    Sample code Fibre length of BSKP L(l) (mm)b Fibre length of BSKP L(l) (mm)c
    Unprocessed BSKPa 1.79 -
    PLA/BSKP1 0.69 0.29
    PLA/BSKP3 0.68 0.35
    PLA/BSKP16 0.84 0.28
    PLA/BSKP25 0.96 0.29
    a Bleached softwood kraft pulp fibre length before compounding and injection moulding.
    b BSKP fibre lengths determined from compounded samples.
    c BSKP fibre lengths determined from injection moulded samples.
     | Show Table
    DownLoad: CSV

    Less cutting to BSKP fibres in the melt compounding is observed as the moisture content of fibres for the feeding is increased as shown in Table 2. By using wet BSKP with higher moisture contents (up to 25%) for feeding in the compounding, the damage (cutting) to fibres is decreased by 39% as compared to the kraft pulp fibres with 1% moisture content in the feeding. This may be due to the fact that never-dried BSKP fibres are not hornificated and thus less brittle than the dried BSKP fibres. Another explanation for this phenomenon is the formation of water vapour on the surface of the kraft pulp fibres during the compounding. This so-called “vapour bed” acts as a protective layer and decrease shear forces subjected to the fibres from polymer melt. Phenomenon is similar to Leidenfrost effect [34,35,36,37]. On the other hand, the formation of the vapour bed restrains the heat transfer into the fibre. In addition, moisture evaporation from the kraft pulp fibre creates a cooling effect and thus fibres are able to retain moisture for a longer period of time.

    As shown in Table 2 injection moulding effectively cuts the BSKP fibres. After injection moulding the kraft pulp fibre lengths of different samples are almost the same. In injection moulding step moisture is already removed from the fibre and thus do not protect the fibres from cutting anymore.


    3.2. SEC

    The average molar weights and polydispersities of neat PLA and PLA/BSKP samples are presented in Table 3. The initial number average (Mn) and weight average (Mw) for the molecular weights of the neat PLA granulates before processing are 154.751 kg mol−1 and 228.181 kg mol−1, respectively. The polydispersity of neat PLA is 1.5. The weight average of the molecular weight of neat PLA granulates decreases through the compounding and injection moulding steps as shown in Table 3. After compounding with BSKP with 1, 3, 16 and 25 wt% moisture contents, lower weight average molecular weights of PLA are recorded. However, after injection moulding Mw values of the PLA/BSKP specimens increase when compared to Mw values of the compounded PLA/BSKP samples. In the melt stage of PLA there exist reactive end groups due to thermal and hydrolytic degradation occurring in the process. This can lead to transesterification and chain coupling in the polymer melt. On the other hand, the use of vacuum for the removal of water from the extruder may to some extent lead to longer polymer chains in the next melt stage [38,39]. PLA tends to degrade when there is excess water in the compounding stage. We suggest that by removing excess water the acidic conditions can be retained which initiates the polymerisation reaction during injection moulding. There is a balance between esterification and transesterification reactions in the melt stage and it can be in relation to the moisture content.

    Table 3.The average molecular weights (Mn, Mw) and polydispersities (PD) of the PLA/BSKP samples after the compounding and injection moulding
    Sample Process Mn (kg mol−1) Mw (kg mol−1) PD Eluent/HPSEC system
    Neat PLA - 154.8 228.2 1.5 Chloroform
    PLA compounding 149.3 223.0 1.5 Chloroform
    injection moulding 143.0 216.0 1.5 Chloroform
    PLA/BSKP1 compounding 139.5 212.6 1.5 Chloroform
    injection moulding 123.7 221.5 1.8 Chloroform
    PLA/BSKP3 compounding 139.0 212.1 1.5 Chloroform
    injection moulding 141.5 226.8 1.6 Chloroform
    PLA/BSKP16 compounding 128.0 198.8 1.6 Chloroform
    injection moulding 130.8 217.6 1.6 Chloroform
    PLA/BSKP25 compounding 126.4 197.6 1.6 Chloroform
    injection moulding 128.2 217.5 1.7 Chloroform
     | Show Table
    DownLoad: CSV

    The polydispersity values of all samples remain relatively constant.


    3.3. Morphological Analysis

    The morphology of the cryo-fractured surfaces of the injection moulded PLA/BSKP composites was studied by SEM. The micrographs indicate that the BSKP fibres were partly attached with the PLA matrix as shown in Figure 2a-d. Some void spaces between the BSKP fibre and the PLA matrix were detected. SEM studies revealed that by using moist never-dried pulp fibres in the compounding resulted in a moderate fibre-matrix adhesion in the injection moulded specimens. PLA/BSKP1 and PLA/BSKP3 showed improved tensile strength and modulus, which may indicate a better fibre-matrix interaction or an improved fibre dispersion when compared to PLA/BSKP16 and PLA/BSKP25 samples. However, SEM micrographs do not reveal a clear fibre-matrix adhesion difference when using never-dried fibres with various moisture contents in the melt processing.

    Figure 2. SEM images of the cryo-fractured surfaces of the PLA/BSKP dumbbell specimens with the same magnification: (a) PLA/BSKP1, (b) PLA/BSKP3, (c) PLA/BSKP16 and (d) PLA/BSKP25

    3.4. Mechanical Properties

    The mechanical properties of the PLA/BSKP composites with standard deviations are summarized in Table 3. The addition of 30 wt% BSKP with various moisture contents resulted in improved strength and stiffness of all the composites when compared to the neat PLA. Tensile strength improved from 62.7MPa for neat PLA to 73.1 MPa for PLA/BSKP3. Similarly, strength enhanced from 62.7 MPa for neat PLA to 72.8 MPa, 70.6 MPa and 70.4 MPa for PLA/BSKP1, PLA/BSKP16 and PLA/BSKP25, respectively. The highest improvement in Young’s modulus was obtained from the PLA/BSKP16 composite in comparison with the neat PLA. The incorporation of the BSKP with various moisture contents deteriorated the strain and impact strength of PLA. Lower strain and impact strength can be explained by the voids between the kraft pulp fibres and PLA matrix resulting in reduced fibre-matrix adhesion in the composite. After the injection moulding BSKP3 retained the highest fibre length among other fibres. The longer fibre length together with the higher molar mass of PLA in the PLA/BSKP3 sample may explain the superior tensile strength. We believe that the tensile modulus or the material stiffness is related to good fibre dispersion in a polymer matrix. We suggest that the degradation of PLA decreases the molecular weight while water acts as a plasticizer for the kraft pulp fibres during the compounding. Degraded PLA together with water decreases the viscosity of the polymer melt which may lead to improved fibre dispersion during the compounding stage and also reflects the better properties of the composites after injection moulding.

    Table 4.Mechanical properties of PLA and PLA/BSKP composites
    Sample code Tensile strength (MPa) Young’s modulus (GPa) Elongation at max stress (%) Impact strength (kJ/m2)
    PLA 62.7 ± 0.3 3.38 ± 0.1 2.28 ± 0 16.4 ± 1.1
    PLA/BSKP1 72.8 ± 0.7 6.19 ± 0.1 1.85 ± 0.1 14.3 ± 1.6
    PLA/BSKP3 73.1 ± 0.3 6.21 ± 0.1 1.87 ± 0.1 13.9 ± 1.7
    PLA/BSKP16 70.6 ± 1.2 6.67 ± 0.1 1.50 ± 0.1 13.1 ± 1.7
    PLA/BSKP25 70.4 ± 0.8 5.91 ± 0.3 1.75 ± 0.1 14.2 ± 1.3
     | Show Table
    DownLoad: CSV
    Figure 3. Effect of bleached softwood kraft pulp (BSKP) moisture contents on the mechanical properties of PLA

    4. Conclusion

    Kraft pulp fibres are mainly used in the form of dried pulp sheets or never-dried pulp in thermoplastic composites. Prior to compounding pulp sheets need to be grounded and pelletized. In the first place, wetting of pulp fibres is required for the pellet production. Secondly, pulp fibres need to dried after pelletizing. When never-dried pulp is used it can be pelletized wet and dried. It is common practise to dry natural fibres as dry as possible prior to processing with PLA. This usually requires use of vacuum dryers and non-humid feeding system with protective gas in processing. In this way, the degradation of PLA during processing can be minimized. Dried cellulose has a very high moisture absorption tendency directly from the air. Usually this behavior complicates the use of cellulose in thermoplastic composite processing.

    Pulp drying consumes a huge amount of energy. It is estimated that the energy consumption in pulp drying is about 2.8-4.0 gigajoule/ton evaporated water. However, the energy consumption is determined by the drying method [40]. The average cost of energy across Europe was 0.08 €/kWh [41].

    This paper presents a promising and advantageous route to produce bleached softwood kraft pulp reinforced PLA composites via compounding and injection moulding. By using moist never-dried bleached softwood kraft pulp for feeding, the kraft pulp fibre cutting during the melt processing is decreased. This phenomenon can be explained by the less brittle features of moist never-dried BSKP fibres when compared to dried BSKP fibres. On the other hand, water present in the BSKP fibres during compounding may act as a plasticizer for the fibres. It is suggested that water together with degraded PLA reduces the viscosity of the polymer melt. The reduction of melt viscosity leads to reduction in shear forces in the latter stage of compounding before the vacuum treatment and thus less cutting to BSKP fibres occurs.

    According to these trials it seems that moist BSKP could be successfully used in PLA compounding and there is no need for intensified drying of the kraft pulp fibres. moist present in the kraft pulp does not necessarily deteriorate the final properties of PLA. By avoiding the use of additional drying steps or protective gas facilitates processing and results in cost savings. First of all, this study demonstrates that the cellulose fibre length can be retained in the compounding stage when using never-dried fibres for feeding. We suggest that with the optimum initial moisture content of BSKP (for example 3 wt%), the most cost-effective processing method for injection moulded PLA/BSKP composites is achieved.


    Acknowledgements

    This work was a part of ACel program of the Clic Innovations Ltd. The financial support from the Finnish Funding Agency for Technology and Innovation (TEKES) is gratefully acknowledged. We would like to thank Atte Mikkelson for the SEC measurements.


    Conflict of Interests

    The authors declare that there is no conflict of interests regarding the publication of this paper.


    [1] da Silva HB, Amaral EP, Nolasco EL, et al. (2013) Dissecting major signaling pathways throughout the development of prostate cancer. Prostate Cancer 2013: 920612.
    [2] Chang H, Brown CW, Matzuk MM (2002) Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocr Rev 23: 787-823. doi: 10.1210/er.2002-0003
    [3] Massagué J (2008) TGFβ in cancer. Cell 134: 215-230. doi: 10.1016/j.cell.2008.07.001
    [4] Zhang YE (2009) Non-Smad pathways in TGF-β signaling. Cell Res 19: 128-139. doi: 10.1038/cr.2008.328
    [5] Heldin C-H, Moustakas A (2016) Signaling Receptors for TGF-β Family Members. Cold Spring Harb Perspect Biol 8: a022053. doi: 10.1101/cshperspect.a022053
    [6] Morikawa M, Derynck R, Miyazono K (2016) TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology. Cold Spring Harb Perspect Biol 8: a021873. doi: 10.1101/cshperspect.a021873
    [7] Jenkins G (2008) The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol 40: 1068-1078. doi: 10.1016/j.biocel.2007.11.026
    [8] Johnson KE, Makanji Y, Temple-Smith P, et al. (2016) Biological activity and in vivo half-life of pro-activin A in male rats. Mol Cell Endocrinol 422: 84-92. doi: 10.1016/j.mce.2015.12.007
    [9] Walton KL, Kelly EK, Chan KL, et al. (2015) Inhibin biosynthesis and activity are limited by a prodomain-derived peptide. Endocrinology 156: 3047-3057. doi: 10.1210/en.2014-2005
    [10] Walton KL, Makanji Y, Harrison CA (2012) New insights into the mechanisms of activin action and inhibition. Mol Cell Endocrinol 359: 2-12. doi: 10.1016/j.mce.2011.06.030
    [11] De Caestecker M (2004) The transforming growth factor-β superfamily of receptors. Cytokine Growth Factor Rev 15: 1-11. doi: 10.1016/j.cytogfr.2003.10.004
    [12] Brodin G, ten Dijke P, Funa K, et al. (1999) Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration. Cancer Res 59: 2731-2738.
    [13] Shi Y, Massagué J (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113: 685-700. doi: 10.1016/S0092-8674(03)00432-X
    [14] Sun PD, Davies DR (1995) The cystine-knot growth-factor superfamily. Annu Rev Biophys Biomol Struct 24: 269-291. doi: 10.1146/annurev.bb.24.060195.001413
    [15] Lebrun J-J (2012) The dual role of TGF in human cancer: from tumor suppression to cancer metastasis. ISRN Mol Biol 2012.
    [16] Bierie B, Moses HL (2006) Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520. doi: 10.1038/nrc1926
    [17] Xie L, Law BK, Chytil AM, et al. (2004) Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro. Neoplasia 6: 603-610. doi: 10.1593/neo.04241
    [18] Beck C, Schreiber H, Rowley DA (2001) Role of TGF-β in immune-evasion of cancer. Microsc Res Tech 52: 387-395.
    [19] Margheri F, Schiavone N, Papucci L, et al. (2012) GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides. PLoS One 7: e50342. doi: 10.1371/journal.pone.0050342
    [20] Futakuchi M, Nannuru KC, Varney ML, et al. (2009) Transforming growth factor-β signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation. Cancer Sci 100: 71-81. doi: 10.1111/j.1349-7006.2008.01012.x
    [21] Sugatani T, Alvarez U, Hruska K (2003) Activin A stimulates IκB‐α/NFκB and rank expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors. J Cell Biochem 90: 59-67. doi: 10.1002/jcb.10613
    [22] Gupta DK, Singh N, Sahu DK (2014) TGF-β Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma. Cancer Growth Metastasis 7: 1.
    [23] Marino FE, Risbridger G, Gold E (2013) The therapeutic potential of blocking the activin signalling pathway. Cytokine Growth Factor Rev 24: 477-484. doi: 10.1016/j.cytogfr.2013.04.006
    [24] Siegel PM, Massagué J (2003) Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer 3: 807-820. doi: 10.1038/nrc1208
    [25] Irigoyen J, Munoz-Canoves P, Montero L, et al. (1999) The plasminogen activator system: biology and regulation. Cell Mol Life Sci 56: 104-132. doi: 10.1007/PL00000615
    [26] Li WY, Chong SS, Huang EY, et al. (2003) Plasminogen activator/plasmin system: a major player in wound healing? Wound Repair Regen 11: 239-247. doi: 10.1046/j.1524-475X.2003.11402.x
    [27] Pulukuri SM, Gondi CS, Lakka SS, et al. (2005) RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J Biol Chem 280: 36529-36540. doi: 10.1074/jbc.M503111200
    [28] Hartwell KA, Muir B, Reinhardt F, et al. (2006) The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci U S A 103: 18969-18974. doi: 10.1073/pnas.0608636103
    [29] Padua D, Massagué J (2009) Roles of TGFβ in metastasis. Cell Res 19: 89-102. doi: 10.1038/cr.2008.316
    [30] Mundy GR (2002) Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593. doi: 10.1038/nrc867
    [31] Logothetis CJ, Lin S-H (2005) Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 5: 21-28. doi: 10.1038/nrc1528
    [32] Chen G, Deng C, Li Y-P (2012) TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8: 272-288. doi: 10.7150/ijbs.2929
    [33] Tsuchida K, Nakatani M, Hitachi K, et al. (2009) Activin signaling as an emerging target for therapeutic interventions. Cell Commun Signal 7: 10.1186. doi: 10.1186/1478-811X-7-10
    [34] Buijs J, Van Der Horst G, Van Den Hoogen C, et al. (2012) The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation. Oncogene 31: 2164-2174. doi: 10.1038/onc.2011.400
    [35] Schnepp B, Hua X (2003) A Tumor Suppressing Duo: TGFβ and Activin Modulate a Similar Transcriptome. Cancer Biol Ther 2: 171-172. doi: 10.4161/cbt.2.2.334
    [36] Mittl PR, Priestle JP, Cox DA, et al. (1996) The crystal structure of TGF‐β3 and comparison to TGF‐β2: implications for receptor binding. Protein Science 5: 1261-1271. doi: 10.1002/pro.5560050705
    [37] Gatherer D, Ten Dijke P, Baird DT, et al. (1990) Expression of TGF-isoforms during first trimester human embryogenesis. Development 110: 445-460.
    [38] Millan FA, Denhez F, Kondaiah P, et al. (1991) Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 111: 131-143.
    [39] Pelton RW, Saxena B, Jones M, et al. (1991) Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 115: 1091-1105. doi: 10.1083/jcb.115.4.1091
    [40] López-Casillas F, Wrana JL, Massagué J (1993) Betaglycan presents ligand to the TGFβ signaling receptor. Cell 73: 1435-1444. doi: 10.1016/0092-8674(93)90368-Z
    [41] Piek E, Heldin C-H, Ten Dijke P (1999) Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J 13: 2105-2124.
    [42] David D, Nair SA, Pillai MR (2013) Smurf E3 ubiquitin ligases at the cross roads of oncogenesis and tumor suppression. Biochim Biophys Acta 1835: 119-128.
    [43] Robertson IB, Horiguchi M, Zilberberg L, et al. (2015) Latent TGF-β-binding proteins. Matrix Biology 47: 44-53. doi: 10.1016/j.matbio.2015.05.005
    [44] Butz H, Rácz K, Hunyady L, et al. (2012) Crosstalk between TGF-β signaling and the microRNA machinery. Trends Pharmacol Sci 33: 382-393. doi: 10.1016/j.tips.2012.04.003
    [45] Zhong H, Wang H-R, Yang S, et al. (2010) Targeting Smad4 links microRNA-146a to the TGF-β pathway during retinoid acid induction in acute promyelocytic leukemia cell line. Int J Hematol 92: 129-135. doi: 10.1007/s12185-010-0626-5
    [46] Ottley E, Gold E (2014) microRNA and non-canonical TGF-β signalling: Implications for prostate cancer therapy. Crit Rev Oncol Hematol 92: 49-60. doi: 10.1016/j.critrevonc.2014.05.011
    [47] van den Bosch MH, Blom AB, van Lent PL, et al. (2014) Canonical Wnt signaling skews TGF-β signaling in chondrocytes towards signaling via ALK1 and Smad 1/5/8. Cell Signal 26: 951-958. doi: 10.1016/j.cellsig.2014.01.021
    [48] Grönroos E, Kingston IJ, Ramachandran A, et al. (2012) Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes. Mol Cell Biol 32: 2904-2916. doi: 10.1128/MCB.00231-12
    [49] Liu IM, Schilling SH, Knouse KA, et al. (2009) TGFβ‐stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro‐migratory TGFβ switch. EMBO J 28: 88-98. doi: 10.1038/emboj.2008.266
    [50] Perry KT, Anthony CT, Steiner MS (1997) Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in normal and malignant human prostate. Prostate 33: 133-140.
    [51] Danielpour D (2005) Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate. Eur J Cancer 41: 846-857. doi: 10.1016/j.ejca.2004.12.027
    [52] Dallas SL, Zhao S, Cramer SD, et al. (2005) Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen. J Cell Physiol 202: 361-370. doi: 10.1002/jcp.20147
    [53] Laverty H, Wakefield L, Occleston N, et al. (2009) TGF-β3 and cancer: a review. Cytokine Growth Factor Rev 20: 305-317. doi: 10.1016/j.cytogfr.2009.07.002
    [54] Parada D, Arciniegas E, Moreira O, et al. (2003) Transforming growth factor-beta2 and beta3 expression in carcinoma of the prostate. Arch Esp Urol 57: 93-99.
    [55] Djonov V, Ball RK, Graf S, et al. (1997) Transforming growth factor‐β3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinoma. Prostate 31: 103-109.
    [56] Hisataki T, Itoh N, Suzuki K, et al. (2004) Modulation of phenotype of human prostatic stromal cells by transforming growth factor‐betas. Prostate 58: 174-182. doi: 10.1002/pros.10320
    [57] Ao M, Williams K, Bhowmick NA, et al. (2006) Transforming growth factor-β promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res 66: 8007-8016. doi: 10.1158/0008-5472.CAN-05-4451
    [58] Wikström P, Stattin P, Franck‐Lissbrant I, et al. (1998) Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate 37: 19-29.
    [59] Steiner MS, Barrack ER (1992) Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol Endocrinol 6: 15-25.
    [60] Steiner MS, Zhou Z-Z, Tonb DC, et al. (1994) Expression of transforming growth factor-beta 1 in prostate cancer. Endocrinology 135: 2240-2247.
    [61] Mu Y, Sundar R, Thakur N, et al. (2011) TRAF6 ubiquitinates TGF [beta] type I receptor to promote its cleavage and nuclear translocation in cancer. Nat Commun 2: 330. doi: 10.1038/ncomms1332
    [62] Wan Y, Yang M, Kolattukudy S, et al. (2010) Activation of cAMP-responsive-element-binding protein by PI3 kinase and p38 MAPK is essential for elevated expression of transforming growth factor β2 in cancer cells. J Interferon Cytokine Res 30: 677-681. doi: 10.1089/jir.2009.0117
    [63] Bang Y-J, Kim S-J, Danielpour D, et al. (1992) Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3. Proc Natl Acad Sci U S A 89: 3556-3560. doi: 10.1073/pnas.89.8.3556
    [64] Cho HJ, Baek KE, Saika S, et al. (2007) Snail is required for transforming growth factor-β-induced epithelial–mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun 353: 337-343. doi: 10.1016/j.bbrc.2006.12.035
    [65] Walker L, Millena AC, Strong N, et al. (2013) Expression of TGFβ3 and its effects on migratory and invasive behavior of prostate cancer cells: involvement of PI3-kinase/AKT signaling pathway. Clin Exp Metastasis 30: 13-23. doi: 10.1007/s10585-012-9494-0
    [66] Vo BT, Morton Jr D, Komaragiri S, et al. (2013) TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway. Endocrinology 154: 1768-1779. doi: 10.1210/en.2012-2074
    [67] Williams RH, Stapleton A, Yang G, et al. (1996) Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study. Clin Cancer Res 2: 635-640.
    [68] Demagny H, De Robertis EM (2015) Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling. Mol Cell Oncol: e989133.
    [69] Hahn SA, Schutte M, Hoque AS, et al. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21. 1. Science 271: 350-353. doi: 10.1126/science.271.5247.350
    [70] Papageorgis P (2015) TGFbeta Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis. J Oncol 2015: 587193.
    [71] Hofmann TG, Stollberg N, Schmitz ML, et al. (2003) HIPK2 regulates transforming growth factor-β-induced c-Jun NH2-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 63: 8271-8277.
    [72] Edlund S, Bu S, Schuster N, et al. (2003) Transforming Growth Factor-β1 (TGF-β)–induced Apoptosis of Prostate Cancer Cells Involves Smad7-dependent Activation of p38 by TGF-β-activated Kinase 1 and Mitogen-activated Protein Kinase Kinase 3. Mol Biol Cell 14: 529-544. doi: 10.1091/mbc.02-03-0037
    [73] Kang H-Y, Huang K-E, Chang SY, et al. (2002) Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J Biol Chem 277: 43749-43756. doi: 10.1074/jbc.M205603200
    [74] Micke P (2004) Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 45: S163-S175. doi: 10.1016/j.lungcan.2004.07.977
    [75] Sheng J, Chen W, Zhu HJ (2015) The immune suppressive function of transforming growth factor-beta (TGF-beta) in human diseases. Growth Factors 33: 92-101. doi: 10.3109/08977194.2015.1010645
    [76] Mu Y, Gudey SK, Landström M (2012) Non-Smad signaling pathways. Cell Tissue Res 347: 11-20. doi: 10.1007/s00441-011-1201-y
    [77] Thompson TB, Cook RW, Chapman SC, et al. (2004) Beta A versus beta B: is it merely a matter of expression? Mol Cell Endocrinol 225: 9-17. doi: 10.1016/j.mce.2004.02.007
    [78] Ryu B, Kern SE (2003) The essential similarity of TGFβ and activin receptor transcriptional responses in cancer cells. Cancer Biol Ther 2: 164-170. doi: 10.4161/cbt.2.2.276
    [79] Loomans HA, Andl CD (2014) Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion. Cancers 7: 70-91. doi: 10.3390/cancers7010070
    [80] Gold E, Marino FE, Harrison C, et al. (2013) Activin‐βc reduces reproductive tumour progression and abolishes cancer‐associated cachexia in inhibin‐deficient mice. J Pathol 229: 599-607. doi: 10.1002/path.4142
    [81] Marino FE, Risbridger G, Gold E (2014) The inhibin/activin signalling pathway in human gonadal and adrenal cancers. Mol Hum Reprod 20: 1223-1237. doi: 10.1093/molehr/gau074
    [82] Mellor SL, Cranfield M, Ries R, et al. (2000) Localization of Activin βA-, β B-, andβ C-Subunits in Human Prostate and Evidence for Formation of New Activin Heterodimers ofβ C-Subunit 1. J Clin Endocrinol Metab 85: 4851-4858.
    [83] Mellor SL, Ball EM, O'Connor AE, et al. (2003) Activin βC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate. Endocrinology 144: 4410-4419. doi: 10.1210/en.2003-0225
    [84] Stenvers KL, Findlay JK (2010) Inhibins: from reproductive hormones to tumor suppressors. Trends Endocrinol Metab 21: 174-180. doi: 10.1016/j.tem.2009.11.009
    [85] Walton KL, Makanji Y, Wilce MC, et al. (2009) A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor β (TGFβ) ligands. J Biol Chem 284: 9311-9320. doi: 10.1074/jbc.M808763200
    [86] Johnson KE, Makanji Y, Temple-Smith P, et al. (2016) Biological activity and in vivo half-life of pro-activin A in male rats. Mol Cell Endocrinol 422: 84-92. doi: 10.1016/j.mce.2015.12.007
    [87] Sheth A, Panse G, Vaze A, et al. (1981) Inhibin in the human prostate. Arch Androl 6: 317-321. doi: 10.3109/01485018108987543
    [88] Sathe VS, Sheth NA, Phadke MA, et al. (1987) Biosynthesis and localization of inhibin in human prostate. Prostate 10: 33-43. doi: 10.1002/pros.2990100107
    [89] Thomas TZ, Wang H, Niclasen P, et al. (1997) Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer. J Clin Endocrinol Metab 82: 3851-3858. doi: 10.1210/jcem.82.11.4374
    [90] Balanathan P, Ball EM, Wang H, et al. (2004) Epigenetic regulation of inhibin alpha-subunit gene in prostate cancer cell lines. J Mol Endocrinol 32: 55-67. doi: 10.1677/jme.0.0320055
    [91] Mellor SL, Richards MG, Pedersen JS, et al. (1998) Loss of the Expression and Localization of Inhibinα-Subunit in High Grade Prostate Cancer 1. J Clin Endocrinol Metab 83: 969-975.
    [92] Risbridger G, Shibata A, Ferguson K, et al. (2004) Elevated expression of inhibin α in prostate cancer. J Urol 171: 192-196. doi: 10.1097/01.ju.0000100048.98807.b7
    [93] Matzuk M, Finegold M, Mather J, et al. (1994) Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A 91: 8817-8821. doi: 10.1073/pnas.91.19.8817
    [94] Coerver KA, Woodruff TK, Finegold MJ, et al. (1996) Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Mol Endocrinol 10: 534-543.
    [95] Dalkin A, Gilrain J, Bradshaw D, et al. (1996) Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells. Endocrinology 137: 5230-5235.
    [96] Liu QY, Niranjan B, Gomes P, et al. (1996) Inhibitory effects of activin on the growth and morphogenesis of primary and transformed mammary epithelial cells. Cancer Res 56: 1155-1163.
    [97] Valderrama-Carvajal H, Cocolakis E, Lacerte A, et al. (2002) Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat Cell Biol 4: 963-969. doi: 10.1038/ncb885
    [98] Leto G, Incorvaia L, Badalamenti G, et al. (2006) Activin A circulating levels in patients with bone metastasis from breast or prostate cancer. Clin Exp Metastasis 23: 117-122. doi: 10.1007/s10585-006-9010-5
    [99] Sottnik JL, Keller ET (2013) Understanding and targeting osteoclastic activity in prostate cancer bone metastases. Curr Mol Med 13: 626-639. doi: 10.2174/1566524011313040012
    [100] Gold E, Jetly N, O'Bryan MK, et al. (2009) Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo. Am J Pathol 174: 184-195. doi: 10.2353/ajpath.2009.080296
    [101] Wakefield LM, Hill CS (2013) Beyond TGFβ: roles of other TGFβ superfamily members in cancer. Nat Rev Cancer 13: 328-341. doi: 10.1038/nrc3500
    [102] Katagiri T, Watabe T (2016) Bone Morphogenetic Proteins. Cold Spring Harb Perspect Biol 8: a021899. doi: 10.1101/cshperspect.a021899
    [103] Wozney JM, Rosen V, Celeste AJ, et al. (1988) Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534. doi: 10.1126/science.3201241
    [104] Balboni AL, Cherukuri P, Ung M, et al. (2015) p53 and ΔNp63α Coregulate the Transcriptional and Cellular Response to TGFβ and BMP Signals. Mol Cancer Res 13: 732-742. doi: 10.1158/1541-7786.MCR-14-0152-T
    [105] Herpin A, Lelong C, Favrel P (2004) Transforming growth factor-beta-related proteins: an ancestral and widespread superfamily of cytokines in metazoans. Dev Comp Immunol 28: 461-485. doi: 10.1016/j.dci.2003.09.007
    [106] Pils D, Wittinger M, Petz M, et al. (2010) BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-ß treatment. Gynecol Oncol 117: 189-197. doi: 10.1016/j.ygyno.2009.12.034
    [107] Cao X, Chen D (2005) The BMP signaling and in vivo bone formation. Gene 357: 1-8. doi: 10.1016/j.gene.2005.06.017
    [108] Onichtchouk D, Chen Y-G, Dosch R, et al. (1999) Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature 401: 480-485. doi: 10.1038/46794
    [109] Gamer LW, Cox K, Carlo JM, et al. (2009) Overexpression of BMP3 in the developing skeleton alters endochondral bone formation resulting in spontaneous rib fractures. Dev Dynam 238: 2374-2381. doi: 10.1002/dvdy.22048
    [110] Gamer LW, Nove J, Levin M, et al. (2005) BMP-3 is a novel inhibitor of both activin and BMP-4 signaling in Xenopus embryos. Dev Biol 285: 156-168. doi: 10.1016/j.ydbio.2005.06.012
    [111] Stewart A, Guan H, Yang K (2010) BMP‐3 promotes mesenchymal stem cell proliferation through the TGF‐β/activin signaling pathway. J Cell Physiol 223: 658-666.
    [112] Olsen OE, Wader KF, Hella H, et al. (2015) Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B. Cell Commun Signal 13: 27. doi: 10.1186/s12964-015-0104-z
    [113] Harris SE, Harris MA, Mahy P, et al. (1994) Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate 24: 204-211. doi: 10.1002/pros.2990240406
    [114] Masuda H, Fukabori Y, Nakano K, et al. (2004) Expression of bone morphogenetic protein‐7 (BMP‐7) in human prostate. Prostate 59: 101-106. doi: 10.1002/pros.20030
    [115] Lamm ML, Podlasek CA, Barnett DH, et al. (2001) Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. Dev Biol 232: 301-314. doi: 10.1006/dbio.2001.0187
    [116] Ye L, Lewis-Russell JM, Kyanaston HG, et al. (2007) Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histol Histopathol 22: 1129-1147.
    [117] Dai J, Keller J, Zhang J, et al. (2005) Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res 65: 8274-8285. doi: 10.1158/0008-5472.CAN-05-1891
    [118] Liao A, Wang W, Sun D, et al. (2014) Bone morphogenetic protein 2 mediates epithelial-mesenchymal transition via AKT and ERK signaling pathways in gastric cancer. Tumour Biol: 1-6.
    [119] Lai TH, Fong YC, Fu WM, et al. (2008) Osteoblasts‐derived BMP‐2 enhances the motility of prostate cancer cells via activation of integrins. Prostate 68: 1341-1353. doi: 10.1002/pros.20799
    [120] Feeley BT, Krenek L, Liu N, et al. (2006) Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone 38: 154-166. doi: 10.1016/j.bone.2005.07.015
    [121] Kwon SJ, Lee GT, Lee JH, et al. (2014) Mechanism of pro‐tumorigenic effect of BMP‐6: Neovascularization involving tumor‐associated macrophages and IL‐1α. Prostate 74: 121-133. doi: 10.1002/pros.22734
    [122] Piccirillo S, Reynolds B, Zanetti N, et al. (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765. doi: 10.1038/nature05349
    [123] Buijs JT, Rentsch CA, van der Horst G, et al. (2007) BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am J Pathol 171: 1047-1057. doi: 10.2353/ajpath.2007.070168
    [124] Bokobza SM, Ye L, Kynaston HG, et al. (2010) GDF‐9 promotes the growth of prostate cancer cells by protecting them from apoptosis. J Cell Physiol 225: 529-536. doi: 10.1002/jcp.22235
    [125] Bokobza SM, Ye L, Kynaston H, et al. (2011) Growth and differentiation factor 9 (GDF-9) induces epithelial–mesenchymal transition in prostate cancer cells. Mol Cell Biochem 349: 33-40. doi: 10.1007/s11010-010-0657-5
    [126] Yan C, Wang P, DeMayo J, et al. (2001) Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 15: 854-866. doi: 10.1210/mend.15.6.0662
    [127] Wu X, Matzuk MM (2002) GDF-9 and BMP-15: oocyte organizers. Rev Endocr Metab Disord 3: 27-32. doi: 10.1023/A:1012796601311
    [128] Peng J, Li Q, Wigglesworth K, et al. (2013) Growth differentiation factor 9: bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions. Proc Natl Acad Sci U S A 110: E776-E785. doi: 10.1073/pnas.1218020110
    [129] Brown DA, Stephan C, Ward RL, et al. (2006) Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis. Clin Cancer Res 12: 89-96. doi: 10.1158/1078-0432.CCR-05-1331
    [130] Aw Yong KM, Zeng Y, Vindivich D, et al. (2014) Morphological effects on expression of growth differentiation factor 15 (GDF15), a marker of metastasis. J Cell Physiol 229: 362-373. doi: 10.1002/jcp.24458
    [131] Kojima M, Troncoso P, Babaian RJ (1998) Influence of noncancerous prostatic tissue volume on prostate-specific antigen. Urology 51: 293-299. doi: 10.1016/S0090-4295(97)00497-4
    [132] Gritsman K, Talbot WS, Schier AF (2000) Nodal signaling patterns the organizer. Development 127: 921-932.
    [133] Gray PC, Harrison CA, Vale W (2003) Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci U S A 100: 5193-5198. doi: 10.1073/pnas.0531290100
    [134] Harrison CA, Gray PC, Vale WW, et al. (2005) Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 16: 73-78. doi: 10.1016/j.tem.2005.01.003
    [135] Yeo C-Y, Whitman M (2001) Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. Mol Cell 7: 949-957. doi: 10.1016/S1097-2765(01)00249-0
    [136] Chen C, Shen MM (2004) Two modes by which Lefty proteins inhibit nodal signaling. Curr Biol 14: 618-624. doi: 10.1016/j.cub.2004.02.042
    [137] Belo JA, Bachiller D, Agius E, et al. (2000) Cerberus-like is a secreted BMP and nodal antagonist not essential for mouse development. Genesis 26: 265-270.
    [138] Lawrence MG, Margaryan NV, Loessner D, et al. (2011) Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells. Prostate 71: 1198-1209. doi: 10.1002/pros.21335
    [139] De Silva T, Ye G, Liang Y-Y, et al. (2012) Nodal promotes glioblastoma cell growth. Frontiers Endocrinol 3: 1-6.
    [140] Aykul S, Ni W, Mutatu W, et al. (2014) Human cerberus prevents nodal-receptor binding, inhibits nodal signaling, and suppresses nodal-mediated phenotypes. PLoS One 10: e0114954.
    [141] Vo BT, Khan SA (2011) Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration. Prostate 71: 1084-1096. doi: 10.1002/pros.21326
    [142] Yingling JM, Blanchard KL, Sawyer JS (2004) Development of TGF-β signalling inhibitors for cancer therapy. Nat Rev Drug Discov 3: 1011-1022. doi: 10.1038/nrd1580
    [143] Isaacs MJ, Kawakami Y, Allendorph GP, et al. (2010) Bone morphogenetic protein-2 and-6 heterodimer illustrates the nature of ligand-receptor assembly. Mol Endocrinol 24: 1469-1477. doi: 10.1210/me.2009-0496
    [144] Neugebauer JM, Kwon S, Kim H-S, et al. (2015) The prodomain of BMP4 is necessary and sufficient to generate stable BMP4/7 heterodimers with enhanced bioactivity in vivo. Proc Natl Acad Sci U S A 112: E2307-E2316. doi: 10.1073/pnas.1501449112
    [145] Yeo C-Y, Whitman M (2001) Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. Mol Cell 7: 949-957. doi: 10.1016/S1097-2765(01)00249-0
    [146] Fuerer C, Nostro MC, Constam DB (2014) Nodal. Gdf1 heterodimers with bound prodomains enable serum-independent nodal signaling and endoderm differentiation. J Biol Chem 289: 17854-17871.
    [147] Harrington AE, Morris‐Triggs SA, Ruotolo BT, et al. (2006) Structural basis for the inhibition of activin signalling by follistatin. EMBO J 25: 1035-1045. doi: 10.1038/sj.emboj.7601000
    [148] Guo X, Wang X-F (2009) Signaling cross-talk between TGF-β/BMP and other pathways. Cell Res 19: 71-88. doi: 10.1038/cr.2008.302
  • This article has been cited by:

    1. Kirsi Immonen, Panu Lahtinen, Jaakko Pere, Effects of Surfactants on the Preparation of Nanocellulose-PLA Composites, 2017, 4, 2306-5354, 91, 10.3390/bioengineering4040091
    2. Xiaohui Yang, Guangzhao Wang, Menghe Miao, Jinquan Yue, Jianxiu Hao, Weihong Wang, The Dispersion of Pulp-Fiber in High-Density Polyethylene via Different Fabrication Processes, 2018, 10, 2073-4360, 122, 10.3390/polym10020122
    3. E. R. T. Tarazona, L. S. Oliveira, J. C. Rubio, A. S. Franca, 2017, Preparation, preliminary characterization and mechanical properties of epoxy composites reinforced with spent coffee grounds, 978-1-5386-3305-2, 21, 10.1109/ICMAE.2017.8038610
    4. Jenna Raunio, Toni Asikainen, Marko Wilo, Emmi Kallio, Levente Csóka, Affecting the bonding between PLA fibrils and kraft pulp for improving paper dry-strength, 2020, 35, 2000-0669, 185, 10.1515/npprj-2019-0033
    5. Sónia Sousa, Ana Paula Costa, Rogério Simões, Poly(lactic acid) composites reinforced with kraft pulp fibres: Production by a papermaking process and characterisation, 2019, 121, 1359835X, 273, 10.1016/j.compositesa.2019.03.024
    6. Heidi Peltola, Kirsi Immonen, Leena‐Sisko Johansson, Jussi Virkajärvi, David Sandquist, Influence of pulp bleaching and compatibilizer selection on performance of pulp fiber reinforced PLA biocomposites, 2019, 136, 0021-8995, 47955, 10.1002/app.47955
    7. Maiju Hietala, Kristiina Oksman, Pelletized cellulose fibres used in twin-screw extrusion for biocomposite manufacturing: Fibre breakage and dispersion, 2018, 109, 1359835X, 538, 10.1016/j.compositesa.2018.04.006
    8. Pia Willberg-Keyriläinen, Hannes Orelma, Jarmo Ropponen, Injection Molding of Thermoplastic Cellulose Esters and Their Compatibility with Poly(Lactic Acid) and Polyethylene, 2018, 11, 1996-1944, 2358, 10.3390/ma11122358
    9. Bruno F. A. Valente, Armando J. D. Silvestre, Carlos Pascoal Neto, Carla Vilela, Carmen S. R. Freire, Effect of the Micronization of Pulp Fibers on the Properties of Green Composites, 2021, 26, 1420-3049, 5594, 10.3390/molecules26185594
    10. Asma Khouaja, Ahmed Koubaa, Hachmi Ben Daly, Dielectric properties and thermal stability of cellulose high-density polyethylene bio-based composites, 2021, 171, 09266690, 113928, 10.1016/j.indcrop.2021.113928
    11. E.F. Sucinda, M.S. Abdul Majid, M.J.M. Ridzuan, E.M. Cheng, H.A. Alshahrani, N. Mamat, Development and characterisation of packaging film from Napier cellulose nanowhisker reinforced polylactic acid (PLA) bionanocomposites, 2021, 187, 01418130, 43, 10.1016/j.ijbiomac.2021.07.069
    12. Kirsi Immonen, Sini Metsä-Kortelainen, Juha Nurmio, Amélie Tribot, Tuomas Turpeinen, Atte Mikkelson, Tomi Kalpio, Otto-Ville Kaukoniemi, Heli Kangas, Recycling of 3D Printable Thermoplastic Cellulose-Composite, 2022, 14, 2071-1050, 2734, 10.3390/su14052734
    13. Wanqing Lei, Jiaqi Du, Zeping Li, Changqing Fang, Jingyu Hou, Xing Zhou, Lu Li, Mannan Yang, Waste paper recycling and its application in modification of the green biodegradable material, 2024, 222, 09266690, 119896, 10.1016/j.indcrop.2024.119896
    14. Ahmad A. L. Ahmad, Siamak Shams Es-haghi, William M. Gramlich, Enhancing Poly(lactic acid) Composites with Polymer-Modified Bleached Softwood Kraft Pulp Before and After Fibrillation, 2024, 6, 2637-6105, 12575, 10.1021/acsapm.4c02149
    15. Martin A. Hubbe, Sustainable Composites: A Review with Critical Questions to Guide Future Initiatives, 2023, 15, 2071-1050, 11088, 10.3390/su151411088
    16. Alina Ruxandra Caramitu, Romeo Cristian Ciobanu, Ioana Ion, Mihai Marin, Eduard-Marius Lungulescu, Virgil Marinescu, Magdalena Aflori, Adriana Mariana Bors, Composites from Recycled Polypropylene and Carboxymethylcellulose with Potential Uses in the Interior Design of Vehicles, 2024, 16, 2073-4360, 2188, 10.3390/polym16152188
    17. Mehmet Akif Dundar, Osman Ozenc, Davut Erdem Sahin, Experimental and numerical investigation of the impact of hemp particle addition on the bending rate-dependent behavior and damage parameters of acrylonitrile-butadiene-styrene, 2025, 1464-4207, 10.1177/14644207251321455
    18. Asma Khouaja, Ahmed Koubaa, Hachmi Ben Daly, Mechanical and morphological properties of cellulose biocomposites, 2025, 379, 00456535, 144415, 10.1016/j.chemosphere.2025.144415
  • Reader Comments
  • © 2017 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(7902) PDF downloads(1183) Cited by(2)

Article outline

Figures and Tables

Figures(3)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog